An analyst from Deutsche Bank maintained GSK plc (LON: GSK) at 'buy' 'buy' with a price target of GBP17.00. Prior to this rating, GSK plc had 9 buy ratings, 9 hold ratings, and 4 sell...
An analyst from Morgan Stanley maintained GSK plc (LON: GSK) at 'equalweight' with a price target of GBP15.85 from a prior price target of %currency%%price%. Prior to this rating, GSK plc...
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (NYSE:GSK) novel treatment, Ojjaara (momelotinib), for adults with intermediate- or high-risk myelofibrosis and...
An analyst from Barclays maintained GSK plc (LON: GSK) at 'equalweight' with a price target of GBP15.75 from a prior price target of %currency%%price%. Prior to this rating, GSK plc had 9...
In a remarkable trading session on Thursday, shares of GSK PLC (LSE:GSK) surged by 1.60%, closing at £14.87. This positive movement was in line with the broader market trend as the FTSE 100...
An analyst from Citi maintained GSK plc (LON: GSK) at 'neutral' with a price target of GBP15.35 from a prior price target of %currency%%price%. Prior to this rating, GSK plc had 9 buy...
An analyst from JPMorgan maintained GSK plc (LON: GSK) at 'underweight' with a price target of GBP13.00 from a prior price target of %currency%%price%. Prior to this rating, GSK plc had 9...
An analyst from HSBC initiated coverage of GSK plc (LON: GSK) at 'reduce' with a price target of GBP11.90. Prior to this rating, GSK plc had 9 buy ratings, 9 hold ratings, and 4 sell...
An analyst from Morgan Stanley maintained GSK plc (LON: GSK) at 'equalweight' with a price target of GBP14.40 from a prior price target of %currency%%price%. Prior to this rating, GSK plc...
An analyst from Jefferies maintained GSK plc (LON: GSK) at 'hold' with a price target of GBP15.25 from a prior price target of %currency%%price%. Prior to this rating, GSK plc had 9 buy...
An analyst from Deutsche Bank maintained GSK plc (LON: GSK) at 'buy' with a price target of GBP17.00. Prior to this rating, GSK plc had 9 buy ratings, 10 hold ratings, and 4 sell...
Investing.com - U.S. bank JPMorgan has maintained its "Underweight" rating for British pharmaceutical company GSK (LON:GSK). At the same time, the analysts set a price target of 1400 pence...
An analyst from Berenberg maintained GSK plc (LON: GSK) at 'buy' with a price target of GBP17.30. Prior to this rating, GSK plc had 9 buy ratings, 10 hold ratings, and 4 sell ratings. For...
An analyst from Deutsche Bank maintained GSK plc (LON: GSK) at 'buy' with a price target of GBP17.00. Prior to this rating, GSK plc had 9 buy ratings, 10 hold ratings, and 4 sell...
An analyst from Deutsche Bank maintained GSK plc (LON: GSK) at 'buy' with a price target of GBP17.00. Prior to this rating, GSK plc had 9 buy ratings, 13 hold ratings, and 2 sell...
A Citi analyst maintained GSK plc (LON: GSK) at Neutral and a price target of $17.00. Prior to this rating, GSK plc had 9 buy ratings, 10 hold ratings, and 4 sell ratings. For consensus...
A Stifel analyst maintained GSK plc (LON: GSK) at Hold and a price target of $15.75 from a prior price target of %currency%%price%. Prior to this rating, GSK plc had 9 buy ratings, 10 hold...
A Jefferies analyst maintained GSK plc (LON: GSK) at Hold and a price target of $15.75. Prior to this rating, GSK plc had 9 buy ratings, 10 hold ratings, and 4 sell ratings. For consensus...
An UBS analyst maintained GSK plc (LON: GSK) at Sell and a price target of $13.00. Prior to this rating, GSK plc had 8 buy ratings, 9 hold ratings, and 4 sell ratings. For consensus...
By Scott Kanowsky Investing.com -- Unilever PLC (LON:ULVR) reported sales growth that was only slightly below analysts' estimates in the fourth quarter, as higher prices helped offset...
By Scott Kanowsky Investing.com -- European equities were mixed on Wednesday but widely held near the flatline, as investors awaited the highly anticipated release of the Federal Reserve's...
By Scott Kanowsky Investing.com -- Shares in GSK plc (LON:GSK) and Sanofi SA (EPA:SASY) soared on Wednesday after the drugmakers saw tens of thousands of lawsuits involving the heartburn...
By Scott Kanowsky Investing.com -- Shares in GlaxoSmithKline (LON:GSK) moved higher on Wednesday after the drugmaker lifted its full-year earnings and sales outlook following...
By Scott Kanowsky Investing.com -- GlaxoSmithKline plc (LON:GSK) has announced that its vaccine for respiratory syncytial virus for adults aged 60 and above showed overall efficacy of...
By Scott Kanowsky Investing.com -- Shares in HALEON PLC (LON:HLN) edged higher after the consumer healthcare firm rejected requests for indemnification from GSK (LON:GSK) and Pfizer ...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
